Jun 25, 2026 08:15AM
Jun 25, 2026 08:15AM
Jun 17, 2026 08:00AM
Jun 17, 2026 08:00AM
Jun 4, 2026 08:02AM
Jun 4, 2026 08:00AM
May 27, 2026 08:00AM MIRA Pharmaceuticals expands Ketamir-2 licensing to worldwide rights
May 27, 2026 08:00AM
May 14, 2026 08:01AM
May 14, 2026 08:00AM
May 13, 2026 08:04AM
May 13, 2026 08:00AM
Mar 23, 2026 09:03AM
Mar 23, 2026 09:00AM MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies
Mar 4, 2026 08:00AM
Mar 4, 2026 08:00AM
Feb 3, 2026 07:31AM
Feb 3, 2026 07:30AM
Oct 24, 2025 07:30AM
Oct 24, 2025 07:30AM
Oct 16, 2025 04:05PM MIRA Pharmaceuticals sells 1.75M shares at 66% premium
Oct 16, 2025 07:30AM
Oct 16, 2025 07:30AM
Sep 30, 2025 07:31AM
Sep 30, 2025 07:30AM
Sep 22, 2025 08:02AM
Sep 22, 2025 08:00AM
Sep 16, 2025 07:30AM Mira Pharma (MIRA) Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
Sep 16, 2025 07:30AM
Sep 15, 2025 04:06PM
Sep 12, 2025 07:30AM
Sep 12, 2025 07:30AM
Aug 19, 2025 08:30AM
Aug 19, 2025 08:30AM
Aug 12, 2025 08:32AM MIRA's Ketamir-2 study accepted for publication in peer-reviewed journal
Aug 12, 2025 08:30AM
Jul 30, 2025 07:30AM
Jul 30, 2025 07:30AM
Jul 29, 2025 07:31AM
Jul 29, 2025 07:30AM
Jul 11, 2025 08:00AM
Jul 11, 2025 08:00AM MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition
Jul 3, 2025 08:02AM
Jul 3, 2025 08:00AM
Jun 30, 2025 08:00AM
Jun 25, 2025 08:00AM
Jun 18, 2025 08:31AM
Jun 18, 2025 08:30AM
Jun 17, 2025 04:06PM Mira Pharma (MIRA) says Ketamir-2 has been accepted for publication in Frontiers in Pharmacology
May 28, 2025 08:30AM

423,287 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All